SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002444
Filing Date
2020-04-20
Accepted
2020-04-20 16:24:28
Documents
13
Period of Report
2020-05-19
Effectiveness Date
2020-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241430zdef14a.htm DEF 14A 5678852
2 G824088.JPG g824088.jpg GRAPHIC 5956
3 G799245.JPG g799245.jpg GRAPHIC 10566
4 G117931.JPG g117931.jpg GRAPHIC 72345
5 G89634.JPG g89634.jpg GRAPHIC 7604
6 G209280.JPG g209280.jpg GRAPHIC 13644
7 G438531.JPG g438531.jpg GRAPHIC 6639
8 G188851.JPG g188851.jpg GRAPHIC 4638
9 G331630.JPG g331630.jpg GRAPHIC 10634
10 G148002MOI001.GIF g148002moi001.gif GRAPHIC 118283
11 G148002MOI002.GIF g148002moi002.gif GRAPHIC 72371
12 G148002MOI003.GIF g148002moi003.gif GRAPHIC 54155
13 G148002MOI004.GIF g148002moi004.gif GRAPHIC 87885
  Complete submission text file 0001047469-20-002444.txt   6320450
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Filer) CIK: 0001586105 (see all company filings)

IRS No.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36295 | Film No.: 20802799
SIC: 2834 Pharmaceutical Preparations